Skip to main content

Table 3 Teratoma imaging with non-18F-FDG radiotracers *1

From: Nuclear medicine imaging in non-seminomatous germ cell tumors: lessons learned from the past failures

Radiotracer class

[Name of the radiotracer]

Research aim

Sample size

Study type

Encouraging results?

First author

(Reference)

Integrins

 - αvβ3 [99mTc-HYNIC-RGD]

Mature teratoma vs. necrosis

20 rats

Preclinical animal study

Yes, for αvβ3 imaging

No, for FDG

Aide [110]

Integrins

 - αvβ3 [99mTc-3PRGD2]

Detection of hiPSC-derived teratoma

4 rats

Preclinical animal study

Yes, for αvβ3 imaging

No, for FDG

Li [67]

Integrins

 αvβ3 [64Cu-DOTA-RGD4]

In vivo visualization of teratoma formation

12 rats

Preclinical animal study

Yes, for αvβ3 imaging

No, for FDG and FLT

Cao [111]

Integrins

 - αvβ3 [99mTc-HYNIC-RGD]

Biodistribution and imaging of αvβ3-negative and positive tumors

4 rats

Preclinical animal study

Equivocal, no definite conclusion regarding the main reason for integrin uptake (i.e., vasculature vs. cellular expression)

Bohn [112]

Radioiodine

 - 124I

In vivo visualization of teratoma formation

9 rats

Preclinical animal study

Yes, highly specific;

Tracer uptake correlated with teratoma weight and washed out with perchlorate

Lehner [113]

18F-FLT [39-deoxy-39–18 F-fluorothymidine]

Added value of FLT on top of FDG PET

11 patients (2 teratoma cases)

Case series

No, FDG and FLT were both falsely negative.

Pfannenberg [63]

67Ga-Citrate

Detection rates in various GU malignancies

11 teratoma cases (16 lesions)

Retrospective clinical cases

No, low detection rate (25%)

Sauerbrunn [72]

PSMA:

 - 68Ga-PSMA/177Lu-PSMA

Single dose of 177Lu-PSMA RLT in a case of refractory mixed GCT

1 patient

Case report

No, rise in AFP and evidence of tumoral progression in the hepatic lesion despite sufficient PSMA uptake

Simsek [66] *2

FAPi:

 - 68Ga-FAPi-04

Comparison with FDG uptake

1 patient

Case report

Equivocal, FAPI (moderate uptake) vs. FDG (low uptake)

Kaplan [1] *3

18F-Fluciclovine

Detection of residual disease/teratoma

10 patients (5 teratoma cases)

Case series

No, low detection rate (40%) in the teratoma subgroup

Woldu [64]

  1. *1 Staging with somatostatin receptor scintigraphy and mIBG has been attempted for teratoma cases associated with TNET. Due to its rarity, the added value of these imaging modalities to conventional imaging is not yet demonstrated [114, 115]. Moreover, there are a few case reports/series for incidental detection of non-seminomatous GCT with 99mTc-pertechnetate and 99mTc-MDP or non-visualization of teratocarcinoma using 201Tl [71,72,73]
  2. *2 Tried in the light of prior human tissue studies [65]
  3. *3 Phase I studies are ongoing [116]
  4. GCT = Germ cell tumor; GU = Genitourinary; hiPSC = human-induced pluripotent stem cell; RLT = Radioligand therapy; TNET = Testicular neuroendocrine tumor